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nents. We have a few comments.
From our animal laboratory experience we do agree that
observed velocity alterations seem to be stent type specific.1 Far
more than just free cell area, however, overall stent design and
procedure related properties such as length, sizing, and self-
expandability all influence post-procedural hemodynamic pertur-
bations and velocities, even in the absence of residual stenosis.3
Secondly, concerning the two predominantly used stents,2 the
Wallstent is an example of a Braided Elgiloy Self-Expanding Stent
(BESES) constructed of independent wires. Acculink has a Surface-
Spanning Micro Stent (SSMS) architecture with interconnected
wires, and this, more than free cell area, influences wall apposition
and subsequent alterations in carotid wall mechanics.
Thirdly, stent placement causes a compliance (Cp) mismatch
between the stented part of the artery and its native upstream and
downstream segments. In diseased arteries, the arterial wall con-
tributes to the overall stiffness of the stented site, and this varies
according to the amount of atherosclerosis and calcium load within
the wall. Therefore, final Cp alters to various degrees, which might
explain why DUS velocities are significantly elevated in a percent-
age of patients but not in all.
Fourth, current stents are self-expanding, and their diameters
steadily increase with time (positive arterial remodelling), poten-
tially achieving better expansion of the lumen.4 Serial measure-
ments of stent diameter confirmed continued expansion after
Wallstent deployment, with most marked expansion occurring
during the first three months. Pierce et al aimed to analyze DUS
before and immediately after stenting. However, post-intervention
DUS was obtained in no less than a median five days (range: 1-25
days). This is a serious study limitation, and timing of postoperative
DUS should have been standardized preferentially within 24 hours
and at three months following the procedure. In the meantime,
vascular laboratories should realize that carotid stent placement
itself leads to elevated velocities, which might well be stent type
specific.
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Reply
We appreciate the astute and thoughtful comments regarding
our study. As outlined, it is certainly clear that many factors
contribute to the elastic modulus and compliance of the carotidartery after stenting, which result in changes in flow hemodynam-
ics. Our data highlights the importance of stent design and its
salient role in demonstrating elevated duplex velocities in the
absence of angiographically demonstrable stenosis after carotid
stenting.
We do agree that the optimal timing of postoperative duplex
ultrasound (DUS) after carotid stenting has not been established,
but we doubt this is a real study limitation. Although initially we
obtained duplex scans within 24 hours after stenting, the timing of
the postoperative DUS was later postponed, primarily as a factor of
study design. Many of the patients in our series were enrolled in
post-marketing registries and clinical trials (eg, SAPPHIRE,
CREST, EMPIRE), all of which require post-intervention DUS at
one month. Because most randomized clinical trials assessing
carotid stenting required postoperative DUS at one and six months
and yearly thereafter, such protocols have been widely adopted in
most centers. We believe that DUS at one month should serve as a
baseline study and that changes in blood flow velocities related to
stent design are validated at this time period. Obtaining DUS at one
and 90 days, as suggested, may be unnecessary, cost-ineffective, and
clinically impractical. Obviously, long-term changes in blood flow
velocities related to stent design and incidence of in-stent restenosis
need to be further investigated. In this regard, we are currently
conducting studies to quantify to what extent stent design differences
in carotid velocities may influence DUS criteria for precisely defining
restenosis after carotid artery stenting.
Damon Scott Pierce, MD
Eric B. Rosero, MD
Carlos H. Timaran, MD
University of Texas Southwestern Medical Center
Dallas, Tex
doi:10.1016/j.jvs.2009.04.051
Regarding “A randomized trial of cryo stripping
versus conventional stripping of the great
saphenous vein”
It was with great interest that we read the article by Klem et
al,1 describing a trial comparing two methods of stripping of the
great saphenous vein (GSV). They are to be complimented on
having presented a clearly honest and large prospective series on
cryo stripping. However, some comments have to be made.
The first comment is on the primary outcome, residual GSV at
6 months. Although it seems likely that residual GSV will influence
the outcome at long-term, little is known about this phenomenon.
We do know that residual veins after endovascular treatment do
not correlate well with clinically recurrent disease. It is a pity,
therefore, that authors did not mention clinical recurrent disease at
follow-up; this should have given us at least an impression, espe-
cially since both techniques performed the same in the quality of
life scores.
Second, I would like to comment on the technique used. Most
surgeons that use the cryo device freeze much shorter than 10
seconds: 3 to 5 seconds suffice to adhere the vein to the probe, and
in such manner, a much smaller part of the adjacent tissue will
freeze together with the vein. Generally thereafter, the vein may be
extracted after invagination, causing less tissue damage, and en-
abling a second or third passage of the probe in case the vein
ruptures during extraction. Invagination is generally not possible
when the cryo probe is used in the “classic” manner, with a large
block of frozen tissue at the tip. The less subtle stripping, and the
necessity of a cosmetically unwanted and time consuming distal
incision in conventional stripping are the main reasons for using
the cryo probe.
Third, I would like to emphasize the fact that significantly
more of the patients lost for follow-up were in the conventional
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“refused to visit the outpatient clinic” all had bad results, no
difference at all remains between groups! Apart from that, a 53%
follow-up at 6 months is not convincing.
Finally, I am rather curious how many procedures were done
by experienced surgeons in the specific kind of surgery, and how
many were by less experienced, such as surgeons in training. This
fact came up because the authors themselves mentioned that in one
center, the first 25 cryo patients did significantly worse than later
on. Also, complications such as persistent lymph drainage in the
groin requiring reoperation—probably induced by large inguinal
incisions, and transection of the common femoral vein—each
mentioned once, are extremely rare (to be estimated 1/10,000
cases) but nevertheless counted for 0.4% of all operations.
Experienced cryo surgeons know well how to manipulate the
leg to advance the probe more distally, which generally results in
increased lengths of extracted veins. The perioperative data on the
length of stripped vein are lacking, however. This makes the case
once more that “simple varicose vein surgery” is not that simple at
all, and are reasons for us to leave all these operations to expert
vascular surgeons or under their direct supervision.
In view of these facts, this large series certainly teaches us
something, but the case that cryo stripping has no benefits over
conventional stripping seems unproven.
Theodore A.A. Vandenbroek, PhD, MD
Waterland Hospital
Surgery
Purmerend, Noord-Holland, The Netherlands
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I want to thank you for the detailed reading of our article. You
have four questions and two conclusions, which I will discuss. You
mentioned it is a pity we did not use clinical recurrent disease at
follow-up, and that both techniques performed the same in the
quality of life (QOL) scores.
Your question raises a more interesting question: What is
clinical recurrent disease? Is it pain, swelling, social dysfunctioning,
or cosmesis? How do you measure these clinical relevant problems,
and how long after surgery? All of these items are addressed as a
secondary end point in the Short-Form 36-Item Health Survey
and the Aberdeen Varicose Vein Questionnaire (AVVQ).
Residual great saphenous vein (GSV) 6 months after the
surgery was chosen because it is an objective measurement. You are
not right about the same performance in the QOL: There was a
small but significant difference between both groups in favor of
conventional stripping.
Second, you mention that the freeze time for most surgeons
who use the cryo device is much shorter than 10 seconds. This is
not our experience. Before the randomized controlled trial started,
one expert vascular surgeon started to use cryo stripping with
different freeze times. A shorter freeze time resulted in a high
incidence of failure because the probe did not adhere to the GSV.The manufacturer of the probe also advises a freeze time of 10
seconds. No information can be found about any advantages of a
shorter freeze time. An invagination strip is preferred, but is
seldom achieved in cryo surgery.
Your third question is about the fact that significantly more
patients—almost two-thirds—were lost to follow-up in the con-
ventional stripping group. You also mentioned that if those 38
patients who “refused to visit the outpatient clinic” all had bad
results, no difference at all remains between groups! You are also
not convinced by a 53% follow-up at 6 months. The truth is more
subtle: Loss to follow-up for the primary end point was 7.6% in the
cryo stripping group and 12.3% in the conventional group. If all
the patients in both groups had not been lost to follow-up and all
had bad results (residual GSV) or good results (no residual GSV),
the primary outcome would still be significantly in favor of
conventional stripping. The large numbers of patients lost to
follow-up for the secondary end point (QOL) is unpleasant in-
deed, but the applied statistics (analysis of variance with adjust-
ments for baseline scores) were sound.
You also mentioned that you are rather curious about how
many procedures were done by experienced surgeons in the spe-
cific kind of surgery, and how many by less experienced surgeons,
such as surgeons in training. You also mentioned that complica-
tions such as persistent lymph drainage in the groin and transection
of the common femoral vein, each mentioned once, are extremely
rare (to be estimated 1/10,000 cases) but nevertheless counted
for complications in 0.4% of all operations. This was a “real life
study.” This means that the operations were performed by sur-
geons in training, general surgeons, and vascular surgeons. All
surgeons had performed at least five cryo stripping procedures
before the randomized controlled trial started to decrease a learn-
ing effect. The first 25 cryo stripping procedures that were per-
formed were possibly worse because there probably was still a
learning effect.
Complications in venous surgery exist, unfortunately, and are
under-reported. Your estimation of 1/10,000 cases is not sup-
ported by the evidence, and the incidence is probably much higher.
Your first conclusion is that “simple varicose vein surgery” is not
that simple at all, and thus is a reason for us to leave all these
operations to expert vascular surgeons or under their direct super-
vision. I do not agree that varicose vein surgery should only be
performed by vascular surgeons. Supervision by a general surgeon
and a meticulous operative technique would suffice. I do agree that
recurrent venous disease should be treated by a vascular surgeon.
Your second conclusion is that in view of these facts, this large
series certainly teaches us something, but the case that cryo strip-
ping has no benefits over conventional stripping seems unproven.
The end of the article stated a mild conclusion: We did not
conclude that cryo stripping is a bad or obsolete operative method.
Regarding the primary outcome (even with the patients lost to
follow-up) and the “real life setting” of this study, there is simply
no evidence that cryo stripping has any benefits over conventional
stripping.
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